✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹3,103 Cr.
P/E
49.02
  • Hikal
  • Suven Life Sciences
  • Piramal Pharma
  • TJI Pharma - API & CRAMS

FAQs on Hikal Ltd. Shareprice

Hikal has given lower returns compared to its competitors.
Hikal has grown at ~-7.92% over the last 2yrs while peers have grown at a median rate of 24.95%

Hikal is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Hikal is 48.8, while 3 year average PE is 46.72.
Also latest EV/EBITDA of Hikal is 12.97 while 3yr average is 17.55.

Growth Table

  • Hikal Ltd.
  • Suven Life Sciences
  • Piramal Pharma

Balance Sheet

  • Hikal Ltd.
  • Suven Life Sciences
  • Piramal Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Hikal Ltd.
  • Suven Life Sciences
  • Piramal Pharma

Cash Flow

  • Hikal Ltd.
  • Suven Life Sciences
  • Piramal Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Hikal Ltd.
  • Suven Life Sciences
  • Piramal Pharma

Quarterly Results

  • Hikal Ltd.
  • Suven Life Sciences
  • Piramal Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Hikal Ltd. Financials

Balance sheet of Hikal is moderately strong, But short term working capital might become an issue for this company.

The net debt of Hikal is decreasing.
Latest net debt of Hikal is ₹726 Crs as of Mar-25.
This is less than Mar-24 when it was ₹773 Crs.

The profit is oscillating.
The profit of Hikal is ₹63.3 Crs for TTM, ₹90.8 Crs for Mar 2025 and ₹69.6 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Hikal latest dividend payout ratio is 19.04% and 3yr average dividend payout ratio is 19.74%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Inventory, Short Term Loans & Advances

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech